TNF-α Inhibitors for the Management of Intractable Corneal Melt: Report of Three Cases and Review of the Literature. Issue 6 (June 2021)
- Record Type:
- Journal Article
- Title:
- TNF-α Inhibitors for the Management of Intractable Corneal Melt: Report of Three Cases and Review of the Literature. Issue 6 (June 2021)
- Main Title:
- TNF-α Inhibitors for the Management of Intractable Corneal Melt
- Authors:
- Utine, Canan Asli
Birlik, Merih
Özizmirliler, Denizcan
Karakaş, Ali
Akbulut, Betül
Durak, Ismet - Abstract:
- Abstract : Objective: To report three consecutive cases with noninfectious corneal melting, whose disease progression could only be halted with tumor necrosis-α (TNF-α) inhibitor infusion, with a review of the relevant literature. Materials and methods: Patients with toxic epidermal necrolysis, severe alkaline burn, and Sjögren syndrome had experienced severe corneal melting following penetrating keratoplasty, Boston type 1 keratoprosthesis implantation or spontaneously, respectively. Topical autologous serum eye-drops, medroxyprogesterone, and acetylcysteine formulations; frequent nonpreserved lubrication; systemic tetracyclines and vitamin-C supplements; topical and systemic steroids and steroid-sparing agents; surgical approaches including amniotic membrane transplantation, tectonic graft surgery; and tarsorraphy failed to alter the disease courses. Results: Upon consultation with the rheumatology clinic, TNF-α inhibitor infliximab (Remicade; Centocor Ortho Biotech Inc, Horsham, PA) 5 mg/kg infusion was planned for each patient. After 0-, 2-, and 6-week doses, monthly infusion at the same dose was maintained for 12 months because of severe and intractable course of their diseases. Each case showed dramatic improvements in corneal melts; and sterile vitritis in the eye with Boston keratoprosthesis responded, as well. Conclusions: Inhibiting TNF-α-mediated expression of matrix metalloproteinases responsible for collagen breakdown should be considered in refractory cases, asAbstract : Objective: To report three consecutive cases with noninfectious corneal melting, whose disease progression could only be halted with tumor necrosis-α (TNF-α) inhibitor infusion, with a review of the relevant literature. Materials and methods: Patients with toxic epidermal necrolysis, severe alkaline burn, and Sjögren syndrome had experienced severe corneal melting following penetrating keratoplasty, Boston type 1 keratoprosthesis implantation or spontaneously, respectively. Topical autologous serum eye-drops, medroxyprogesterone, and acetylcysteine formulations; frequent nonpreserved lubrication; systemic tetracyclines and vitamin-C supplements; topical and systemic steroids and steroid-sparing agents; surgical approaches including amniotic membrane transplantation, tectonic graft surgery; and tarsorraphy failed to alter the disease courses. Results: Upon consultation with the rheumatology clinic, TNF-α inhibitor infliximab (Remicade; Centocor Ortho Biotech Inc, Horsham, PA) 5 mg/kg infusion was planned for each patient. After 0-, 2-, and 6-week doses, monthly infusion at the same dose was maintained for 12 months because of severe and intractable course of their diseases. Each case showed dramatic improvements in corneal melts; and sterile vitritis in the eye with Boston keratoprosthesis responded, as well. Conclusions: Inhibiting TNF-α-mediated expression of matrix metalloproteinases responsible for collagen breakdown should be considered in refractory cases, as a means of globe salvage. … (more)
- Is Part Of:
- Eye & contact lens. Volume 47:Issue 6(2021)
- Journal:
- Eye & contact lens
- Issue:
- Volume 47:Issue 6(2021)
- Issue Display:
- Volume 47, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 47
- Issue:
- 6
- Issue Sort Value:
- 2021-0047-0006-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-06
- Subjects:
- Corneal melting -- Infliximab -- TNF-α inhibitor
Contact lenses -- Periodicals
Intraocular lenses -- Periodicals
Orthokeratology -- Periodicals
Anterior segment (Eye) -- Diseases -- Periodicals
617.7523 - Journal URLs:
- http://journals.lww.com/claojournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/ICL.0000000000000770 ↗
- Languages:
- English
- ISSNs:
- 1542-2321
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3854.587000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25550.xml